This Week in Pediatric Oncology
cancer risk
Episodes
Thursday Jun 15, 2023
Thursday Jun 15, 2023
WATCH THE VIDEO WEBCAST HERE: https://youtu.be/ACFprGG10M0
In this episode, our host, Dr. Timothy Cripe from Nationwide Children’s Hospital, is joined by Dr. Seth Rotz - pediatric hematologist/oncologist and the Director of the Fertility Preservation Program at the Cleveland Clinic in Cleveland, Ohio. Listen in as they discuss Dr. Rotz’s career & specialty in fertility preservation for cancer patients: how he got into the field, what was needed to start the program, & the process and risks associated with oncofertility.
Wednesday Jan 18, 2023
Wednesday Jan 18, 2023
WATCH THE VIDEO WEBCAST HERE: https://youtu.be/oR0KN5VFDVc
Tune in as our host, Dr. Brenda Weigel from the University of Minnesota, is joined by Dr. Garrett Brodeur to discuss his expertise in genetic predispositions in childhood cancer. Dr. Brodeur is the Director of the Pediatric Cancer Predisposition Program at the Children’s Hospital of Philadelphia (CHOP) - and listen in as he discusses his journey leading up to cancer predisposition, what the program entails, as well as the process of screening & surveillance protocols.
To learn more about this program, please visit https://www.chop.edu/centers-programs/hereditary-cancer-predisposition-program
Thursday Nov 10, 2022
Thursday Nov 10, 2022
WATCH THE VIDEO WEBCAST HERE: https://youtu.be/inNQc6x9Jy8
This Week in Pediatric Oncology #102 - November 10, 2022
Tune in as our hosts, Dr. Timothy Cripe & Dr. Brenda Weigel, are joined again by Dr. Douglas Hawkins - who is the current Chair of the Children’s Oncology Group (COG). They discuss in depth the findings of a presented published paper regarding the inequities of childhood cancer outcomes based on external socioeconomic factors such as neighborhood and household poverty.
To read the full paper, visit https://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC7936051&blobtype=pdf
Tuesday Apr 28, 2020
Tuesday Apr 28, 2020
• How is the pandemic changing current cancer care services?• What is the current state of open clinical trials and how will new, near-term trials be affected?• What is the impact on emerging new therapies and translational research?• Are there any silver linings to all of this for childhood cancer research?
These answers and more are discussed in this special episode for cancer families where leaders from COG, the NCI and the pharmaceutical industry lead a community discussion about the pandemic's impact on all aspects of pediatric cancer research including clinical trials and standard cancer care services, followed by Q&A with questions from families and attendees.
We are joined by:- Peter Adamson, MD – former Chair, Children's Oncology Group (COG) and current Global Head, Oncology Development & Pediatric Innovation, Sanofi
- Mark Kieran, MD, PhD – Pediatric Clinical Trial Lead, Bristol Myers Squibb
- Jeffery J. Auletta, MD - Director of the Blood and Marrow Transplant (BMT) Program and the Host Defense and Immunocompromised Infectious Diseases Program at Nationwide Children's Hospital.
- Carol Thiele, Ph.D, Deputy Chief, National Cancer Institute (NCI) Pediatric Oncology Branch
- Prof. Pamela Kearns President, European Society of Pediatric Oncology (SIOPE), Director of Cancer Research UK Clinical Trials Unit
Moderated by: Timothy P. Cripe, MD, PhD – Chief of Hematology and Oncology at Nationwide Children’s Hospital
Hosted by: Solving Kids' Cancer US & UK, and Max Cure Foundation
Tuesday Mar 24, 2020
Tuesday Mar 24, 2020
As our world faces the Novel Coronavirus pandemic, it’s vital that we address key topics important to children & families in the Pediatric Cancer CommunityPlease listen to this informative webinar to hear from experts, ask questions, and share information on:- An overview of COVID-19 pandemic: Fact versus fiction- COVID-19: What are the risks to immunocompromised patients?- Impact of COVID-19 on care and clinical researchExpert Discussion Leaders:Timothy P. Cripe, MD, PhD – Chief of Hematology and Oncology at Nationwide Children’s HospitalJeffery J. Auletta, MD - Director of the Blood and Marrow Transplant (BMT) Program and the Host Defense and Immunocompromised Infectious Diseases Program at Nationwide Children's Hospital.
This audio was taken from a webinar, to watch the full video with resources click here: https://vimeo.com/400382067
Monday Oct 17, 2016
Monday Oct 17, 2016
TWiPO Host Dr. Timothy Cripe, with co-hosts Dr. Nilay Shah and Dr. Bhuvana Setty welcome Dr. Damon Reed, Director of the Adolescent and Young Adult Program at Moffitt Cancer Center and Leader of the Pediatric Cancer Foundation's pediatric phase I consortium, the Sunshine Project. Dr. Reed shares his view points on how we can improve and accelerate the current trajectory with regard to pediatric therapy development.
Wednesday Apr 13, 2016
Wednesday Apr 13, 2016
On today's podcast TWiPO host Dr. Timothy Cripe (Nationwide Children’s Hospital) and co-hosts, Dr. Nilay Shah (Nationwide Children’s Hospital) and Dr. Robyn Dennis (Nationwide Children’s Hospital) Interview Dr. Linda McAllister-Lucas (Chief of Service, Hematology/Oncology of Children's Hospital of Pittsburgh, Associate Professor of Pediatrics, University of Pittsburgh School of Medicine. In their discussion Dr. McAllister-Lucas talks about her research on MALT1 Lymphoma and how this research could advance the field of oncology
Monday Feb 10, 2014
Monday Feb 10, 2014
October
03, 2013
Dr. Joseph Neglia (University of Minnesota) is
nationally and internationally recognized for his contributions to the field of
childhood cancer long-term effects. He is the featured guest in this week's
podcast episode, and answers questions from host Dr. Tim Cripe (Nationwide
Children’s Hospital), and co-hosts Dr. Robyn Dennis (Nationwide Children’s
Hospital), Dr. Andy Kolb (AI DuPont), and Donna Ludwinski (Solving Kids’
Cancer), about late effects and the risk of secondary cancers among childhood
cancer survivors.
Monday Feb 10, 2014
Monday Feb 10, 2014
September
19, 2013
Recently, several published papers have
discussed the risk of cancer among family members of children with
cancer. TWIPO host Dr. Timothy Cripe and fellow co-host Dr. Robyn Dennis
(Nationwide Children's) break down the topic of familial cancer risk with
certified genetic counselor Elizabeth Varga (Nationwide Children's) and Donna
Ludwinski (Solving Kids' Cancer) and what families should take away from these
studies.
Monday Feb 10, 2014
Monday Feb 10, 2014
September
28, 2011
Join host Dr. Tim Cripe with his co-hosts Drs.
Jim Geller, Lionel Chow, and Lars Wagner in a robust discussion with special
guest Dr. Kathryn Wikenheiser-Brokamp on the implications of DICER1, rare tumor
registries, and difficult issues surrounding genetic counseling.
Kathryn A. Wikenheiser-Brokamp, MD, PhD, is an
Associate Professor in Pathology and Pulmonary Biology at Cincinnati Children's
Hospital Medical Center. Her research is focused on pediatric and adult lung diseases,
including cancer. She seeks to determine the molecular mechanisms underlying
Rb/p16, p53, and Dicer1 pathway function in lung development and the
pathogenesis of lung disease. Dr. Wikenheiser-Brokamp holds a PhD in
Developmental Biology, Developmental Biology and an MD from University of
Cincinnati.
Papers discussed:
DICER1 syndrome: clarifying the diagnosis, clinical features and
management implications of a pleiotropic tumour predisposition syndrome.
J Med Genet. 2011 Apr;48(4):273-8.
Extending the Phenotypes Associated with DICER1 Mutations.
Hum Mutat. 2011 Aug 31. doi: 10.1002/humu.21600.
Ovarian sex cord-stromal tumors, pleuropulmonary blastoma and DICER1
mutations: a report from the International Pleuropulmonary Blastoma Registry.
Gynecol Oncol. 2011 Aug;122(2):246-50.
Please send questions or comments to
twipo@solvingkidscancer.org